S. Dahlén (Stockholm, Sweden), C. Taube (Essen, Germany)
Increased pro-inflammatory regulatory T Cells correlate with the plasticity of T helper cell differentiation in asthma
J. Hou (Yinchuan, China), L. Xin (Yinchuan, China), J. Gao (Yinchuan, China), C. Tian (Yinchuan, China), W. Ma (Yinchuan, China), Z. Tian (Yinchuan, China), X. Zheng (Yinchuan, China)
|   |
Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation.
K. Domvri (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece), G. Tzimagiorgis (Thessaloniki, Greece), F. Chatzopoulou (Thessaloniki, Greece), D. Ioannidou (Thessaloniki, Greece), E. Fouka (Thessaloniki, Greece), G. Kyriazis (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece)
|   |
FOXP3 genetic variants are associated with asthma severity in Brazilian women.
C. Figueiredo (Salvador/BA, Brazil), N. Carneiro (Salvador/BA, Brazil), B. Fiuza (Salvador/BA, Brazil), H. Da Silva (Salvador/BA, Brazil), R. Da Silva (Salvador/BA, Brazil), T. Carneiro (Salvador/BA, Brazil), M. Silva (Salvador/BA, Brazil), V. Carneiro (Salvador/BA, Brazil), R. Costa (Salvador/BA, Brazil), J. Fernandes (Salvador/BA, Brazil), L. Cardoso (Salvador/BA, Brazil), A. Cruz Filho (Salvador/BA, Brazil), H. Freitas (Salvador/BA, Brazil)
| |
Variants in IL17A and IL17F are risk factors to uncontrolled asthma
M. Silva (Salvador, Brazil), R. Santos (Salvador, Brazil), I. Brandão (Salvador, Brazil), H. Fonseca (Salvador, Brazil), E. Medeiros (Salvador, Brazil), L. Cardoso (Salvador, Brazil), J. Fernandes (Salvador, Brazil), R. Espinheira (Salvador, Brazil), N. Alcantara-Neves (Salvador, Brazil), A. Cruz (Salvador, Brazil), R. Costa (Salvador, Brazil), C. Figueiredo (Salvador, Brazil)
| |
The new approach to understand the role of IL-15 and BMP proteins in asthma remodelling based on methacholine challenge test evidence.
M. Kocwin (Lodz, Poland), M. Jonakowski (Lodz, Poland), L. Mokros (Lodz, Poland), M. Panek (Lodz, Poland), J. Szemraj (Lodz, Poland), P. Kuna (Lodz, Poland)
| |
Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma
M. Roffel (Groningen, Netherlands), I. Boudewijn (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), K. Bracke (Ghent, Belgium), T. Maes (Ghent, Belgium), I. Heijink (Groningen, Netherlands)
| |
Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
D. Tan (Nedlands, Australia), D. Singh (Manchester, United Kingdom), H. Walters (Tasmania, Australia), P. Wark (Newcastle, Australia), Y. Moodley (Murdoch, Australia)
| |
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
J. Onnipa (Bangkok, Thailand), T. Kawamatawong (Bangkok, Thailand), D. Pitidhammabhorn (Bangkok, Thailand), C. Setthaudom (Bangkok, Thailand)
| |
A novel house dust mite-induced asthma model in guinea pigs driven by mast cells
P. Ramos-Ramirez (Stockholm, Sweden), M. Noreby (Stockholm, Sweden), J. Liu (Stockholm, Sweden), J. Gregory (Stockholm, Sweden), A. Petrén (Stockholm, Sweden), H. Olsson (Mölndal, Sweden), G. Nilsson (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), M. Adner (Stockholm, Sweden)
| |
Mast cell tryptase induce alarmin release and secretion of pro-inflammatory cytokines from bronchial epithelial cells
S. Ramu (Lund, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), L. Uller (Lund, Sweden), C. Andersson (Lund, Sweden)
| |
Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in corticosteroid (CS)-dependent severe asthma patients in LIBERTY ASTHMA VENTURE
K. Rabe (Kiel, Germany), G. Brusselle (Ghent, Belgium), M. Castro (St. Louis, United States of America), L. Sher (Rolling Hills Estates, United States of America), H. Zhu (Bridgewater, United States of America), Q. Dong (Bridgewater, United States of America), J. Hamilton (Tarrytown, United States of America), W. Brian (Bridgewater, United States of America), A. Jagerschmidt (Chilly-Mazarin, France), G. Pirozzi (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
| |
Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)
C. Bachert (Ghent, Belgium), R. Naclerio (Chicago, United States of America), P. Hellings (Leuven, Belgium), S. Guillonneau (Chilly-Mazarin, France), C. Taniou (Nanterre, France), J. Maroni (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France), N. Amin (Tarrytown, United States of America), S. Kamat (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France)
| |
Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST
S. Wenzel (Pittsburgh, United States of America), I. Pavord (Oxford, United Kingdom), K. Rabe (Kiel, Germany), A. Papi (Ferrarra, Italy), J. Fitzgerald (Vancouver, Canada), A. Jagerschmidt (Chilly-Mazarin, France), W. Brian (Chilly-Mazarin, France), Q. Dong (Bridgewater, United States of America), B. Swanson (Bridgewater, United States of America), J. Hamilton (Tarrytown, United States of America), N. Amin (Tarrytown, United States of America), G. Pirozzi (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
| |
Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting ß2-agonist in persistent asthma
M. Hoshino (Atami, Japan), K. Akitsu (Atami, Japan), J. Ohtawa (Atami, Japan)
| |
Safety profile of a novel peptide,PIN201104,with potential to act as a disease modifying,broad spectrum treatment for asthma
J. Watson (Stevenage, United Kingdom), D. Federici-Canova (Stevenage, United Kingdom), N. Cooper (Stevenage, United Kingdom), C. Burgess (Stevenage, United Kingdom)
| |
Bacterial lysates in the prevention of asthma exacerbations in uncontrolled asthma: the Breathe study
G. de Boer (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Tramper (Rotterdam, Netherlands)
| |
The effect of Mepolizumab for not completely satisfied Omlizumab treated asthmatics.
M. Kato (Kishiwada, Osaka, Japan)
| |
Bronchoalveolar lavage transcriptome and eicosanoid profiles reveal heterogeneity of lower airway inflammation in aspirin-exacerbated respiratory disease (AERD)
B. Jakiela (Krakow, Poland), A. Gielicz (Krakow, Poland), H. Plutecka (Krakow, Poland), M. Przybyszowski (Krakow, Poland), J. Soja (Krakow, Poland), K. Sladek (Krakow, Poland), G. Bochenek (Krakow, Poland)
| |